Nephrogenic Systemic Fibrosis Treatment

Nephrogenic systemic fibrosis (NSF) is a rare and serious condition in which fibrous cells multiply in the connective tissues of the eyes, joints, skin and internal organs. Non-genetic and non-contagious, nephrogenic systemic fibrosis is incurable and, without treatment, fatal.

As a result, it's vital that patients diagnosed with nephrogenic systemic fibrosis seek immediate medical attention and follow through with all prescribed treatments. Because there is no cure for this condition, nephrogenic systemic fibrosis treatments involve minimizing a patient's symptoms and preventing the disease from progressing to more severe, life-threatening stages.

Depending on the causes of NSF, patients may be entitled to compensation for their injuries by pursing a nephrogenic systemic fibrosis lawsuit.

Causes of Nephrogenic Systemic Fibrosis

Although researchers are still investigating the range of precise causes of nephrogenic systemic fibrosis, it is currently known that nephrogenic systemic fibrosis can develop following:

  • Use of immunosuppressant drugs, which are prescribed to treat psoriasis, hepatitis C and certain types of cancer
  • Exposure to gadolinium, which is the active ingredient in MRI contrast dyes

MRI contrast dyes, which are injected into patients prior to an MRI, can render the function and/or structure of an internal organ in the resulting image. Brand names of commonly used MRI contrast agents include:

  • Magnevist
  • Multihancee
  • Omniscan
  • OptiMARK

Gadolinium Side Effects

Gadolinium is a silvery-white metallic element that is known to be toxic. Although using gadolinium in MRI dyes can help healthcare professionals diagnose a range of conditions, it can also cause patients – particularly those with a history of kidney disorders – to develop any of the following gadolinium side effects:

  • headache
  • hypotension (significantly low blood pressure)
  • lightheadedness
  • nausea
  • nephrogenic systemic fibrosis
  • severe allergic reaction (characterized by hives, breathing difficulties and facial inflammation)

Currently, nephrogenic systemic fibrosis is the most serious of the known gadolinium side effects.

Treatment Options for Nephrogenic Systemic Fibrosis

To control patient's pain and improve their joint function, doctors may prescribe any combination of the following nephrogenic systemic fibrosis treatments:

  • anti-inflammatory drugs
  • deep tissue massages
  • physical therapy to improve flexibility
  • regular exercise (such as swimming, yoga or other low-impact activities)
  • steroids
  • topical creams (particularly Dovonex, generically known as calcipotriene)

While current NSF treatments are slightly limited, researchers are continuing to investigate new treatment options for nephrogenic systemic fibrosis.

Nephrogenic Systemic Fibrosis Attorneys and Lawsuits

Given the potential causes and severity of nephrogenic systemic fibrosis, most patients diagnosed with this condition will be entitled to a settlement for their medical bills, permanent disabilities and pain and suffering.

Injured patients, as well as families of deceased NSF patients, should set up a free initial consultation with a nephrogenic systemic attorney to:

  • Find out if they have a case and are entitled to compensation
  • Learn more about the process of pursuing a nephrogenic systemic fibrosis lawsuit
  • Get estimates of possible settlement amounts, based on past cases similar to their own

To encourage prospective plaintiffs to seek out the settlements they deserve, nephrogenic systemic fibrosis lawyers will delay payment for their services until the case is won. All consultations are free and confidential.

Have you or a loved one been diagnosed with NSF? If so, contact a nephrogenic systemic fibrosis attorney today for medical and legal resources.

Enter Content Here

Gadolinium Contrast Agents Required to Include New Warning

The U.S. Food and Drug Administration (FDA) issued a news release Sept. 9, 2010, requiring that contrast agents containing gadolinium carry a new warning on their labels because it can lead to nephrogenic systemic fibrosis (NSF). Read More »

First Gadolinium Lawsuit Filed in U.S. Court

An Ohio woman has filed what is believed to be the first gadolinium lawsuit, claiming that the MRI dye Magnevist-made by Bayer-caused her 24-year-old son's death.
Read More »

Gadolinium-Based MRI Dyes Get Black Box Warning

The Food and Drug Administration has asked that a black box warning be added to all gadolinium-based MRI dyes to highlight the risk of nephrogenic systemic fibrosis, or NSF.
Read More »